• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT1与HMGA1表达在非小细胞肺癌中的相关性

Association of SIRT1 and HMGA1 expression in non-small cell lung cancer.

作者信息

Lin Shuang-Yan, Peng Fang

机构信息

Department of Pathology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China.

出版信息

Oncol Lett. 2016 Jan;11(1):782-788. doi: 10.3892/ol.2015.3914. Epub 2015 Nov 13.

DOI:10.3892/ol.2015.3914
PMID:26834854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4726940/
Abstract

The roles of Silent mating type information regulation 2 homolog 1 (SIRT1) and High mobility group A1 (HMGA1) in human diseases have been extensively studied separately; however, to the best of our knowledge, the current study is the first to report on their interrelationship in lung cancer. The association of SIRT1 and HMGA1 in non-small cell lung cancer (NSCLC) was investigated by evaluating their expression and prognostic significance in 260 patients with NSCLC using immunohistochemistry. SIRT1 and HMGA1 expression were found to be significantly correlated with each other (P<0.001), and both were significantly associated with clinicopathological parameters, including histological type and degree of differentiation. In squamous cell carcinoma (SCC), SIRT1 specimens were significantly associated with shorter overall survival (OS) time (P=0.019). However, in patients with adenocarcinoma (AD), no association was identified between SIRT1 and OS. In addition, HMGA1 specimens were significantly associated with poor differentiation (P=0.028), and were more frequent in SCC than AD (P=0.015). However, HMGA1 was not associated with OS on univariate Cox regression analysis or Kaplan-Meier analysis (both P>0.05). SIRT1/HMGA1 coexpression was significantly associated with male gender (P=0.016), and moderately and poorly differentiated histological grade (P=0.025). The findings indicate that SIRT1 and HMGA1 may have significant effects during tumor progression in NSCLC, particularly in patients with SCC, and are potentially useful as prognostic indicators for patients with NSCLC.

摘要

沉默交配型信息调节因子2同源物1(SIRT1)和高迁移率族蛋白A1(HMGA1)在人类疾病中的作用已分别得到广泛研究;然而,据我们所知,当前研究是首次报道它们在肺癌中的相互关系。通过免疫组织化学评估260例非小细胞肺癌(NSCLC)患者中SIRT1和HMGA1的表达及其预后意义,研究了它们在NSCLC中的关联。发现SIRT1和HMGA1表达彼此显著相关(P<0.001),且二者均与包括组织学类型和分化程度在内的临床病理参数显著相关。在鳞状细胞癌(SCC)中,SIRT1标本与总生存(OS)时间较短显著相关(P=0.019)。然而,在腺癌(AD)患者中,未发现SIRT1与OS之间存在关联。此外,HMGA1标本与低分化显著相关(P=0.028),且在SCC中比在AD中更常见(P=0.015)。然而,在单因素Cox回归分析或Kaplan-Meier分析中,HMGA1与OS均无关联(二者P>0.05)。SIRT1/HMGA1共表达与男性性别显著相关(P=0.016),与中低分化组织学分级相关(P=0.025)。这些发现表明,SIRT1和HMGA1可能在NSCLC的肿瘤进展过程中具有显著作用,尤其是在SCC患者中,并且可能作为NSCLC患者的预后指标。

相似文献

1
Association of SIRT1 and HMGA1 expression in non-small cell lung cancer.SIRT1与HMGA1表达在非小细胞肺癌中的相关性
Oncol Lett. 2016 Jan;11(1):782-788. doi: 10.3892/ol.2015.3914. Epub 2015 Nov 13.
2
Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.HMGA1的高表达与非小细胞肺癌的恶性状态及预后相关。
Tumour Biol. 2015 Feb;36(2):1213-9. doi: 10.1007/s13277-014-2749-4. Epub 2014 Oct 25.
3
Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.SIRT1 和 cortactin 的表达与非小细胞肺癌的进展相关。
Pathol Res Pract. 2013 Jun;209(6):365-70. doi: 10.1016/j.prp.2013.03.011. Epub 2013 Apr 15.
4
Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis.SIRT1表达在非小细胞肺癌中的预后及临床病理意义:一项荟萃分析
Oncotarget. 2017 Jul 12;8(37):62537-62544. doi: 10.18632/oncotarget.19244. eCollection 2017 Sep 22.
5
Associations of sirtuins with clinicopathological parameters and prognosis in non-small cell lung cancer.沉默调节蛋白与非小细胞肺癌临床病理参数及预后的相关性
Cancer Manag Res. 2018 Sep 10;10:3341-3356. doi: 10.2147/CMAR.S166946. eCollection 2018.
6
Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.BIRC6和SIRT1蛋白表达水平作为非小细胞肺癌患者潜在预后生物标志物的诊断性研究。
Clin Respir J. 2018 Feb;12(2):633-638. doi: 10.1111/crj.12572. Epub 2016 Nov 20.
7
NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.NQO1蛋白表达预示非小细胞肺癌的预后不良。
BMC Cancer. 2015 Mar 31;15:207. doi: 10.1186/s12885-015-1227-8.
8
Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer.高迁移率族蛋白A1及体重指数在乳腺癌患者预后中的作用
Oncol Lett. 2017 Nov;14(5):5719-5726. doi: 10.3892/ol.2017.6963. Epub 2017 Sep 15.
9
HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.HMGA1 基因在非小细胞肺癌(NSCLC)患者癌组织和血液样本中的表达水平:初步报告。
Mol Genet Genomics. 2022 Nov;297(6):1505-1514. doi: 10.1007/s00438-022-01936-9. Epub 2022 Aug 10.
10
High-mobility group A1 () gene expressions in various colorectal cancer cell lines and correlation with prognosis.高迁移率族蛋白A1(HMGA1)基因在各种结肠癌细胞系中的表达及其与预后的相关性。
Transl Cancer Res. 2020 Feb;9(2):763-773. doi: 10.21037/tcr.2019.12.10.

引用本文的文献

1
HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.HMGA1 基因在非小细胞肺癌(NSCLC)患者癌组织和血液样本中的表达水平:初步报告。
Mol Genet Genomics. 2022 Nov;297(6):1505-1514. doi: 10.1007/s00438-022-01936-9. Epub 2022 Aug 10.
2
Prognostic Significance of Expression in Lung Cancer Based on Bioinformatics Analysis.基于生物信息学分析的肺癌 Expression 的预后意义。
Int J Mol Sci. 2022 Jun 22;23(13):6933. doi: 10.3390/ijms23136933.
3
Discovering the Protective Effects of Resveratrol on Aflatoxin B1-Induced Toxicity: A Whole Transcriptomic Study in a Bovine Hepatocyte Cell Line.发现白藜芦醇对黄曲霉毒素B1诱导毒性的保护作用:牛肝细胞系的全转录组学研究
Antioxidants (Basel). 2021 Jul 29;10(8):1225. doi: 10.3390/antiox10081225.
4
GRP75-mediated upregulation of HMGA1 stimulates stage I lung adenocarcinoma progression by activating JNK/c-JUN signaling.GRP75 通过激活 JNK/c-JUN 信号通路上调 HMGA1 促进 I 期肺腺癌的进展。
Thorac Cancer. 2021 May;12(10):1558-1569. doi: 10.1111/1759-7714.13944. Epub 2021 Mar 23.
5
Deregulation of a -Acting lncRNA in Non-small Cell Lung Cancer May Control HMGA1 Expression.α-肌动蛋白长链非编码RNA在非小细胞肺癌中的失调可能调控高迁移率族蛋白A1(HMGA1)的表达。
Front Genet. 2021 Jan 11;11:615378. doi: 10.3389/fgene.2020.615378. eCollection 2020.
6
Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling.hsa-miR-217 通过靶向 SIRT1 和 P53/KAI1 信号抑制非小细胞肺癌细胞的增殖、迁移和侵袭。
Balkan Med J. 2020 Jun 1;37(1):208-214. doi: 10.4274/balkanmedj.galenos.2020.2019.9.91. Epub 2020 Apr 9.
7
Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy.神经母细胞瘤中假定的预后和预测标志物的比较分析:PBX1高表达与诱导治疗反应不佳相关。
Front Oncol. 2019 Nov 15;9:1221. doi: 10.3389/fonc.2019.01221. eCollection 2019.
8
Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.泛素特异性蛋白酶22/沉默信息调节因子1轴在肝细胞癌的预后和5-氟尿嘧啶耐药中起关键作用。
Dig Dis Sci. 2020 Apr;65(4):1064-1073. doi: 10.1007/s10620-019-05844-8. Epub 2019 Oct 5.
9
Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis.SIRT1表达在癌症中的生存及临床病理意义:一项Meta分析
Front Endocrinol (Lausanne). 2019 Mar 13;10:121. doi: 10.3389/fendo.2019.00121. eCollection 2019.
10
MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells.微小RNA-4458通过靶向高迁移率族蛋白A1抑制非小细胞肺癌细胞的迁移和上皮-间质转化。
Cancer Manag Res. 2019 Jan 10;11:637-649. doi: 10.2147/CMAR.S185117. eCollection 2019.

本文引用的文献

1
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.沉默调节蛋白1和2的表达与非小细胞肺癌患者的不良预后相关。
PLoS One. 2015 Apr 27;10(4):e0124670. doi: 10.1371/journal.pone.0124670. eCollection 2015.
2
SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC.SIRT1表达与晚期非小细胞肺癌患者的化疗反应及预后相关。
PLoS One. 2013 Nov 5;8(11):e79162. doi: 10.1371/journal.pone.0079162. eCollection 2013.
3
Resveratrol Inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1.白藜芦醇通过增强 Sirt1 的表达和活性来抑制 CD4+T 细胞的活化。
PLoS One. 2013 Sep 20;8(9):e75139. doi: 10.1371/journal.pone.0075139. eCollection 2013.
4
SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.SIRT1表达与结直肠癌的良好预后相关。
Korean J Pathol. 2013 Aug;47(4):332-9. doi: 10.4132/KoreanJPathol.2013.47.4.332. Epub 2013 Aug 26.
5
Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.SIRT1 和 cortactin 的表达与非小细胞肺癌的进展相关。
Pathol Res Pract. 2013 Jun;209(6):365-70. doi: 10.1016/j.prp.2013.03.011. Epub 2013 Apr 15.
6
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.一个阈值机制在细胞生长抑制和细胞凋亡之间调节着 p53 细胞命运的决定。
Cell Death Differ. 2013 Apr;20(4):576-88. doi: 10.1038/cdd.2012.155. Epub 2013 Jan 11.
7
DBC1 does not function as a negative regulator of SIRT1 in liver cancer.在肝癌中,DBC1并非作为SIRT1的负调控因子发挥作用。
Oncol Lett. 2012 Nov;4(5):873-877. doi: 10.3892/ol.2012.875. Epub 2012 Aug 23.
8
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.E-钙黏蛋白、皮层肌动蛋白和基质金属蛋白酶-9在头颈部假上皮瘤样增生和鳞状细胞癌中的表达:它们与临床病理因素的关系及预后意义
Korean J Pathol. 2012 Aug;46(4):331-40. doi: 10.4132/KoreanJPathol.2012.46.4.331. Epub 2012 Aug 23.
9
SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.SIRT1 和 c-Myc 促进肝癌细胞存活并预测人肝细胞癌的不良预后。
PLoS One. 2012;7(9):e45119. doi: 10.1371/journal.pone.0045119. Epub 2012 Sep 14.
10
High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.高迁移率族蛋白 A1 蛋白通过与线粒体中的 Bcl-2 相互作用抑制 p53 介导的内在凋亡。
Cell Death Dis. 2012 Aug 30;3(8):e383. doi: 10.1038/cddis.2012.126.